Diabetes
Showing NaN - NaN of 45
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin detemir, insulin aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin detemir
- insulin aspart
-
Fresno, California
- +68 more
Jan 30, 2017
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin detemir, insulin glargine)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin detemir
- insulin glargine
-
Litchfield Park, Arizona
- +87 more
Jan 30, 2017
Diabetes, Diabetes, Type 2 Trial in Mexico, Puerto Rico, United States (liraglutide, glimepiride, )
Terminated
- Diabetes
- Diabetes Mellitus, Type 2
- liraglutide
- +2 more
-
Concord, California
- +116 more
Jan 24, 2017
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec, insulin aspart, liraglutide)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec
- +2 more
-
Concord, California
- +123 more
Jan 20, 2017
Diabetes, Diabetes, Type 1 Trial in Worldwide (liraglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- liraglutide
- placebo
-
Little Rock, Arkansas
- +181 more
Jan 16, 2017
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec, insulin glargine)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec
- insulin glargine
-
Northridge, California
- +98 more
Jan 20, 2017
Diabetes Trial in Worldwide (Insulin sensitizer)
Completed
- Diabetes
- Insulin sensitizer
-
Hollywood, Florida
- +45 more
Feb 28, 2017
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin aspart, insulin detemir)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin aspart
- insulin detemir
-
Birmingham, Alabama
- +66 more
Jan 2, 2017
Diabetes, Diabetes, Type 2 Trial in Puerto Rico, United States (repaglinide and metformin combination tablet, rosiglitazone and
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- repaglinide and metformin combination tablet
- rosiglitazone and metformin combination tablet
-
Vestavia, Alabama
- +102 more
Feb 9, 2017
Diabetes, Diabetes, Type 1 Trial in Worldwide (insulin degludec, insulin glargine, insulin aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- insulin degludec
- +2 more
-
Encino, California
- +81 more
Dec 16, 2016
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec, insulin glargine)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec
- insulin glargine
-
Bay Minette, Alabama
- +186 more
Dec 16, 2016
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin detemir, insulin NPH)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin detemir
- insulin NPH
-
Birmingham, Alabama
- +95 more
Jan 27, 2017
Diabetes, Diabetes, Type 2 Trial in United States (biphasic insulin aspart, pioglitazone, metformin)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- biphasic insulin aspart
- +2 more
-
Birmingham, Alabama
- +72 more
Jan 10, 2017
Diabetes, Diabetes, Type 2 Trial in Puerto Rico, United States (biphasic insulin aspart, insulin glargine)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- biphasic insulin aspart
- insulin glargine
-
Birmingham, Alabama
- +72 more
Jan 10, 2017
Diabetes, Diabetes, Type 2 Trial in United States (biphasic insulin aspart, insulin glargine, metformin)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- biphasic insulin aspart
- +3 more
-
Concord, California
- +26 more
Jan 6, 2017
Diabetes, Diabetes, Type 1 Trial in United States (insulin human, insulin lispro, insulin aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- insulin human
- +2 more
-
Birmingham, Alabama
- +75 more
Dec 21, 2016
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/insulin aspart, insulin glargine)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec/insulin aspart
- insulin glargine
-
Birmingham, Alabama
- +91 more
Oct 26, 2016
Diabetes Trial in Worldwide (Ro 205-2349)
Completed
- Diabetes
- Ro 205-2349
-
Huntsville, Alabama
- +116 more
Aug 23, 2016